Latest News & Features
Americas
Teva has sued Mylan for alleged patent infringement over Copaxone, a treatment for patients with relapsing-remitting forms of multiple sclerosis. 18 January 2017
Biotechnology
UK-based Horizon Discovery has broadened its gene editing capabilities through the amendment of a pre-existing licence with ERS Genomics to include the full commercial rights for the use of CRISPR. 17 January 2017
Americas
Monosol Rx, a speciality pharmaceutical company, has filed a complaint against BioDelivery Sciences International for alleged patent infringement. 17 January 2017
Big Pharma
The English High Court has referred a supplementary protection certificate dispute over Truvada to Europe’s highest court, the Court of Justice of the European Union. 16 January 2017
Americas
The US Supreme Court has agreed to hear the biosimilars dispute between Amgen and Sandoz. 16 January 2017
Americas
Sanofi and Genzyme have filed a complaint against Mylan for patent infringement over the drug Aubagio, a treatment for relapsing forms of multiple sclerosis. 13 January 2017
Americas
The US Court of Appeals for the Federal Circuit has affirmed a ruling by a district court giving a win to Eli Lilly in a patent case against Teva. 13 January 2017
Americas
Rochester Drug Co-operative, a wholesaler serving community retail pharmacy and home healthcare dealers, has filed a class action complaint against Shire and Actavis in a competition case centring on ADHD drug Intuniv. 12 January 2017
Americas
A US District Court has denied Sanofi and Regeneron’s motion to suspend an injunction which was obtained by Amgen earlier this month. 12 January 2017
Americas
Squire Patton Boggs has hired Thomas Anderton as of counsel in its intellectual property and technology practice in San Francisco. 12 January 2017